MEGAN MCBRIDE: Open Payments
NPI 1437712031 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,071 in 47 payments from 12 companies in 2025. Trend: 2023 $914 · 2024 $1,279 · 2025 $1,071
Food & beverage: $996Education: $75
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $334 |
| Novartis Pharmaceuticals Corporation | 7 | $178 |
| Janssen Biotech, Inc. | 6 | $160 |
| Regeneron Healthcare Solutions, Inc. | 3 | $105 |
| KYOWA KIRIN, INC. | 2 | $58 |
| Aimmune Therapeutics, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $50 |
| Organon LLC | 2 | $40 |
| Surgenex LLC | 1 | $33 |
| UCB, Inc. | 1 | $25 |
Products named: COSENTYX, TREMFYA, SKYRIZI, BOTOX, DUPIXENT, POTELIGEO, ZENPEP, HADLIMA.
Industry payments across AZ — which companies pay providers there.
